Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

BUY
$7.94 - $11.84 $8,273 - $12,337
1,042 Added 1240.48%
1,126 $9,000
Q4 2022

Feb 13, 2023

SELL
$10.5 - $14.2 $283 - $383
-27 Reduced 24.32%
84 $0
Q3 2022

Oct 27, 2022

BUY
$10.79 - $14.81 $291 - $399
27 Added 32.14%
111 $1,000
Q2 2022

Aug 01, 2022

SELL
$7.89 - $17.88 $94,806 - $214,846
-12,016 Reduced 99.31%
84 $1,000
Q1 2022

May 11, 2022

BUY
$11.56 - $19.76 $5,780 - $9,880
500 Added 4.31%
12,100 $197,000
Q4 2021

Feb 11, 2022

BUY
$11.18 - $15.46 $33,607 - $46,472
3,006 Added 34.98%
11,600 $161,000
Q3 2021

Nov 10, 2021

BUY
$14.21 - $17.65 $2,756 - $3,424
194 Added 2.31%
8,594 $123,000
Q2 2021

Aug 05, 2021

SELL
$9.5 - $17.24 $28,500 - $51,719
-3,000 Reduced 26.32%
8,400 $133,000
Q1 2021

Apr 28, 2021

BUY
$7.37 - $13.61 $69,278 - $127,934
9,400 Added 470.0%
11,400 $116,000
Q4 2020

Feb 04, 2021

BUY
$3.37 - $8.61 $6,740 - $17,220
2,000 New
2,000 $15,000
Q3 2020

Nov 10, 2020

SELL
$3.43 - $5.53 $3,430 - $5,530
-1,000 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$1.9 - $5.61 $1,900 - $5,610
1,000 New
1,000 $5,000
Q4 2019

Feb 04, 2020

SELL
$1.59 - $3.45 $7,390 - $16,035
-4,648 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$2.91 - $9.15 $12,518 - $39,363
4,302 Added 1243.35%
4,648 $18,000
Q1 2019

May 08, 2019

BUY
$7.38 - $9.72 $2,553 - $3,363
346 New
346 $3,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.42B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.